Hemophilia A (HA) is the X-linked bleeding disorder that results from highly heterogeneous loss-of-function factor (F) VIII (FVIII) gene (F8) mutations and variably deficient-to-absent plasma FVIII coagulant activity (FVIII:C). This evidence concerns the gene F8 and hemophilia A.